EGTX.ST Stock — Price, Charts & Analysis
Egetis Therapeutics AB Stock Fundamentals & Technical Report
Egetis Therapeutics AB (EGTX.ST) is reviewed here as a complete stock research report, bringing the core signals into one place: today's price action, valuation, earnings power, balance-sheet quality, cash flow, dividends, ownership, analyst expectations, RSI, support, resistance, moving averages, and technical momentum. The report is built from the data available on Worldtickers and keeps the company name front and center while preserving the ticker for quick market lookup.
Egetis Therapeutics AB Fundamental Analysis
Egetis Therapeutics AB Company Profile
Where is Egetis Therapeutics AB headquartered?
Egetis Therapeutics AB is headquartered in Sweden. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.
Egetis Therapeutics AB Technical Analysis
What is Egetis Therapeutics AB's RSI?
EGTX.ST's RSI is 64.96. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.
What is Egetis Therapeutics AB's RSI today?
EGTX.ST's latest RSI reading is 64.96, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.
What are Egetis Therapeutics AB's support and resistance levels?
Key support for EGTX.ST is near $5.86. Key resistance is near $7.35. Breaks above resistance or below support can change the short-term technical setup.
What is the support level for Egetis Therapeutics AB?
EGTX.ST's nearest reported support level is $5.86. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.
What is the resistance level for Egetis Therapeutics AB?
EGTX.ST's nearest reported resistance level is $7.35. A breakout above resistance can improve momentum, especially when volume confirms the move.
What is Egetis Therapeutics AB's MACD?
EGTX.ST's MACD is 0.00, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.
Should I buy Egetis Therapeutics AB based on technical analysis?
RSI is 64.96 (neutral). MACD is bullish. Nearest support is around $5.86. Resistance is around $7.35. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.
Where is Egetis Therapeutics AB versus its 20-day, 50-day, and 200-day moving averages?
MA20 is $6.78 (8.14% from price). MA50 is $6.27 (16.88% from price). MA200 is $5.63 (30.29% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.
What is Egetis Therapeutics AB's EMA signal?
The server report currently confirms daily moving-average levels rather than a separate EMA-only value. EGTX.ST's MA20 is $6.78. MA50 is $6.27. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.
What are Egetis Therapeutics AB's pivot, support, and resistance levels?
EGTX.ST's pivot is near $6.84. Support is near $5.86. Resistance is near $7.35. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.
What are the next support and resistance zones for Egetis Therapeutics AB?
The next lower support zone for EGTX.ST is near $7.00. These levels help define risk and possible follow-through zones after a breakout or breakdown.
What do Bollinger Bands show for Egetis Therapeutics AB?
EGTX.ST's Bollinger range is roughly $5.98 to $7.58. Band width is near 23.56%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.
What is Egetis Therapeutics AB's ATR volatility?
EGTX.ST's ATR-based typical daily range is about 4.17%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.
AI Market Desk
Free plan